Medidata continues IPO thaw, looks to raise $86M
Medidata Solutions, a company that streamlines clinical development and research processes for biotech firms, announced the terms of its IPO today — setting its price per share at $11 to $13 for 6.3 million shares. The sale could generate as much as $86.3 million for the New York-based company and mark the third U.S. software IPO in 2009 (behind Rosetta Stone and SolarWinds).
The money brought in will be used for several capital expenditures and prospective… Continue Reading
Outside.in gets fresh funding for local news
Local news and discussion site Outside.in has raised an undisclosed amount of new funding from existing investors. Let’s hope the New York startup has enough money now to keep the going during a tough time for many media and news organizations.
Local search sites like Judy’s Book have failed, but it looks like Outside.in co-founder John Geraci may have been right when he told us the competition just launched too early; Outside.in says traffic grew 400… Continue Reading
Guidester rebrands as Searchandise, raises $7.5M
Guidester, a search merchandising company, has rebranded itself as Searchandise Commerce and raised a $7.5 million third round of funding, according to VentureWire. The company also has a new home-base, moving its headquarters from New York to Beverly, Mass.
Using Searchandise’s core product HitList, manufacturers can make cost-per-click bids to retailers to obtain a high-profile spot on their search results. The retailer gets extra revenue, the merchandiser gets the online equivalent of a prominent in-store display.
Searchandise’s… Continue Reading
Outside.in gets $3M and a new CEO for local news
Outside.in, a site for community news and discussion, has raised an additional $3 million and appointed a new chief executive.
The Brooklyn, New York startup named Mark Josephson, former president of marketing company Seevast Corp., as its new CEO. Josephson doesn’t appear to have experience in local news or local content, but that may not be a problem, since sites like Outside.in are still experimenting to find the best approach. His most relevant experience may be… Continue Reading
Life sciences briefing: Monday, Sept. 24, 2007
Featured companies: Adnexus Therapeutics, Bristol-Myers Squibb, Cellerix, Elixir Therapeutics, GenomeQuest, Intronn, JapanBridge, JenaValve, VirXsys, Ysios Capital
[NOTE: This item is a catchup daily briefing originally posted on 9/27/07. I've edited the item's timestamp to preserve the chronological order of the briefings. --D.P.H.]
Adnexus Thera cancels IPO, sells itself to Bristol-Myers for $430M — Waltham, Mass.-based Adnexus Therapeutics, a biotech pursuing drugs against cancer and other diseases, said it would cancel plans for its IPO and instead sell… Continue Reading